MAGEA4 and sarcoma: However, it does not seem that everything can go smoothly and the TME of mild progressive STSs and highly aggressive sarcomas like UPS, MFS, and MPNST would have different roles for NY-ESO-1 and MAGEA4 according to another report [145].